# To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

> **NCT06970275** · — · RECRUITING · sponsor: **XEOS Medical** · enrollment: 850 (estimated)

## Conditions studied

- Prostate Cancers
- Breast Cancer
- Head and Neck Cancer
- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06970275
- **Lead sponsor:** XEOS Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-19
- **Primary completion:** 2031-01-15
- **Final completion:** 2031-01-15
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06970275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06970275, "To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06970275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*